1. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
    Jie Lan et al, 2018, International Journal of Radiation Oncology*Biology*Physics CrossRef
  2. Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazine-induced colorectal carcinogenesis of rats
    I.V. Byelinska et al, 2014, Fiziol Zh CrossRef
  3. SIRS, CARS and MARS in relationship to cancer cachexia and its clinical implications
    Masahiko Shibata et al, 2018, ACRT CrossRef
  4. Genetic variation determines VEGF-A plasma levels in cancer patients
    Federico Innocenti et al, 2018, Sci Rep CrossRef
  5. The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set
    Song Ryo et al, 2018, Ann Surg Oncol CrossRef
  6. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma
    Yajuan Lv et al, 2019, Medicine CrossRef
  7. null
    Masahiko Shibata et al, 2016 CrossRef
  8. Neutrophil to lymphocyte ratio is superior to platelet to lymphocyte ratio as an early predictor of moderate/severe ovarian hyperstimulation syndrome
    F. F. Verit et al, 2014, Journal of Obstetrics and Gynaecology CrossRef
  9. New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk
    Ai-Min Zhao et al, 2016, Journal of Reproductive Immunology CrossRef
  10. null
    A. Lapeyre-Prost et al, 2017 CrossRef
  11. Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma
    Yu Sato et al, 2017 CrossRef
  12. IL-17 and VEGF are significantly associated with disease progression involving systemic inflammation in patients with gastric and colorectal cancers
    Kazuo Minamikawa et al, 2017, ACRT CrossRef
  13. IL-17 and VEGF are increased and correlated to systemic inflammation, immune suppression, and malnutrition in patients with breast cancer
    Kazunoshin Tachibana et al, 2017, Eur J Inflamm CrossRef
  14. A CMOS VEGF Sensor for Cancer Diagnosis Using a Peptide Aptamer-Based Functionalized Microneedle
    Seungwoo Song et al, 2019, IEEE Trans. Biomed. Circuits Syst. CrossRef
  15. Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma
    Laure Hirsch et al, 2020, Drugs CrossRef
  16. Elevated neutrophil‑to‑lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S‑1 plus cisplatin, and poor prognosis in patients with stage?IV gastric cancer
    Kenji Gonda et al, 2017, mol clin onc CrossRef
  17. Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial
    Andrea Casadei Gardini et al, 2020, Ther Adv Med Oncol CrossRef
  18. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
    Naoki Horikawa et al, 2017, Clin Cancer Res CrossRef
  19. Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)
    Gregory N. Dietsch et al, 2015, Clin Cancer Res CrossRef
  20. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia
    Aldona Kasprzak, 2021, IJMS CrossRef
  21. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
    Vera M. Kho et al, 2021, Cellular Immunology CrossRef
  22. Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy
    Rahmawati Minhajat et al, 2021, Journal of Coloproctology CrossRef
  23. Tumor-Induced Myeloid-Derived Suppressor Cells
    Francesco De Sanctis et al, 2016, Microbiol Spectr CrossRef
  24. Inhibiting VEGF in cancer immunotherapy
    Masahiko Shibata et al, 2021, Clinical Immunology Communications CrossRef
  25. Low body mass index is associated with reduced intratumoral CD4+ T-lymphocyte infiltration in laryngeal squamous cell carcinoma patients
    Luana Dalbem Murad et al, 2022, Nutrition Research CrossRef
  26. The Clinical Application Value of the Prognostic Nutritional Index for the Overall Survival Prognosis of Patients with Esophageal Cancer: A Robust Real-World Observational Study in China
    Juanjuan Kang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  27. null
    Tsung-Wen Sun et al, 2022 CrossRef
  28. Neutrophil:lymphocyte and estradiol:progesterone ratios as predictive markers for ovarian hyperstimulation syndrome (OHSS)
    Emre Baser et al, 2021, Reprod. Fertil. Dev. CrossRef
  29. A Low-Power Sensing System of VEGF Concentration With Noise Reduction Using Subsampling Technique for Cancer Diagnosis
    Tsung-Heng Tsai et al, 2023, IEEE Sensors J. CrossRef
  30. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle‐invasive bladder cancer after surgery
    Jincheng Wang et al, 2023, Cancer Medicine CrossRef
  31. Value of a preoperative prognostic nutritional index for the prognostic evaluation of gastric neuroendocrine carcinoma patients
    Jiangpeng Wei et al, 2023, Front. Nutr. CrossRef
  32. Pretreatment controlling nutritional status (CONUT) score and carcinoembryonic antigen level provide tumor progression and prognostic information in gastric cancer: A retrospective study
    Xiuqing Chen et al, 2023 CrossRef
  33. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review
    Piotr Domański et al, 2024, Medicina CrossRef